Urinary tract infections: Advances and new therapies

BJU International

Volumn 93, Issue 6, 2004, Pages 690-691

  Kucheria, R ^a   Sheerin, N S ^a   Dasgupta, P ^a,b   Khan, M S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL VACCINE; DEFENSIN;

BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; CELL ACTIVITY; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELL WALL; CHEMICAL STRUCTURE; CLINICAL TRIAL; FUNGICIDAL ACTIVITY; GRAM NEGATIVE BACTERIUM; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; MICROBIAL ACTIVITY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; URINARY TRACT INFECTION;

ANIMALS; BACTERIAL VACCINES; HUMANS; MICE; URINARY TRACT INFECTIONS;

EID: 1942478537     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.04754.x     Document Type: Note

References (6)

1. Ganz T. Defensins. Antimicrobial peptides of innate immunity Nature Rev Immunol 2003; 3: 710-20
2. Doyle SE, O'Connell RM, Miranda GA et al. Toll-like receptors induce a phagocytic gene program through p38. J Exp Med 2004; 199: 81-90
3. Mulvey MA, Joel SD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infection Immunity 2001; 69: 4572-9
4. Springall T, Sheerin NS, Abe K, Holers VM, Wan H, Sacks SH. Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli. Nature Med 2001; 7: 803-8
5. Langermann S, Mollby R, Burlein JE. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infectious Dis 2000; 181: 774-8
6. Uehling DT, Hopkins WJ, Elkahwaji JE, Schmidt DM, Leverson GE. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. J Urol 2003; 170: 867-9